Niculescu-Duvaz; Dan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Niculescu-Duvaz; Dan.The latest application filed is for "lysyl oxidase inhibitors".

Company Profile

5.25.23

Niculescu-Duvaz; Dan - Manchester GB
NICULESCU-DUVAZ; Dan - Macclesfield GB
Niculescu-Duvaz; Dan - Sutton GB
Niculescu-Duvaz; Dan - Sutton Surrey GB
Niculescu-Duvaz; Dan - Surrey GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lysyl Oxidase Inhibitors App 20220289757 - Marais; Richard ; et al.	2022-09-15
Lysyl oxidase inhibitors Grant 11,325,915 - Marais , et al. May 10, 2	2022-05-10
Lox Inhibitors App 20220017516 - ALJARAH; Mohammed ; et al.	2022-01-20
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer Grant 10,995,088 - Springer , et al. May 4, 2	2021-05-04
Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer App 20210040078 - SPRINGER; Caroline ; et al.	2021-02-11
Lysyl Oxidase Inhibitors App 20200331922 - Marais; Richard ; et al.	2020-10-22
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer Grant 10,807,974 - Springer , et al. October 20, 2	2020-10-20
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer Grant 10,167,282 - Springer , et al. J	2019-01-01
Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives Grant 10,100,053 - Zambon , et al. October 16, 2	2018-10-16
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy Grant 9,820,976 - Springer , et al. November 21, 2	2017-11-21
1 -(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4h-pyrido[2, 3-b]pyrazin-8-yl)oxy]phenyl]urea Derivatives As Raf Inhibitors For The Treatment Of Cancer App 20170298066 - SPRINGER; Caroline Joy ; et al.	2017-10-19
Process For The Preparation Of 8-(4-aminophenoxy)-4h-pyrido[2,3-b]pyrazin-3-one Derivatives App 20170298065 - Zambon; Alfonso ; et al.	2017-10-19
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b- ]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer Grant 9,725,447 - Springer , et al. August 8, 2	2017-08-08
Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives Grant 9,708,317 - Zambon , et al. July 18, 2	2017-07-18
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use Grant 9,611,223 - Ashworth , et al. April 4, 2	2017-04-04
1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea And Related Compounds And Their Use In Therapy App 20170079963 - SPRINGER; Caroline Joy ; et al.	2017-03-23
Pyrido[2,3-b]pyrazin-8-substituted compounds and their use Grant 9,540,372 - Springer , et al. January 10, 2	2017-01-10
1 -(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4h-pyrido[2, 3-b]pyrazin-8-yl)oxy]phenyl]urea Derivatives As Raf Inhibitors For The Treatment Of Cancer App 20160355510 - SPRINGER; Caroline Joy ; et al.	2016-12-08
Process For The Preparation Of 8-(4-aminophenoxy)-4h-pyrido[2,3-b]pyrazin-3-one Derivatives App 20160297814 - Zambon; Alfonso ; et al.	2016-10-13
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy Grant 9,439,893 - Springer , et al. September 13, 2	2016-09-13
3-aryl-5-substituted-isoquinolin-1-one Compounds And Their Therapeutic Use App 20160221953 - ASHWORTH; Alan ; et al.	2016-08-04
1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea And Related Compounds And Their Use In Therapy App 20160030405 - SPRINGER; Caroline ; et al.	2016-02-04
Pyrido[2,3-b]pyrazin-8-substituted Compounds And Their Use App 20160002230 - SPRINGER; Caroline Joy ; et al.	2016-01-07
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use Grant 9,193,689 - Ashworth , et al. November 24, 2	2015-11-24
Pyrido[2,3-B]pyrazin-8-substituted compounds and their use Grant 9,155,737 - Springer , et al. October 13, 2	2015-10-13
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy Grant 9,120,789 - Springer , et al. September 1, 2	2015-09-01
Pyrido[2,3-b]pyrazin-8-substituted Compounds And Their Use App 20150182526 - SPRINGER; Caroline Joy ; et al.	2015-07-02
3-aryl-5-substituted-isoquinolin-1-one Compounds And Their Therapeutic Use App 20150099732 - Ashworth; Alan ; et al.	2015-04-09
Pyrido[2,3-B]pyrazin-8-substituted compounds and their use Grant 8,912,191 - Springer , et al. December 16, 2	2014-12-16
1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-ureaand Related Compounds And Their Use In Therapy App 20140357663 - SPRINGER; Caroline ; et al.	2014-12-04
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy Grant 8,815,896 - Springer , et al. August 26, 2	2014-08-26
Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use App 20140121212 - Springer; Caroline Joy ; et al.	2014-05-01
Pyrido[2,3-b]pyrazin-8-substituted compounds and their use Grant 8,546,387 - Springer , et al. October 1, 2	2013-10-01
Aryl-quinolyl compounds and their use Grant 8,383,816 - Niculescu-Duvaz , et al. February 26, 2	2013-02-26
1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,- 3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea And Related Compounds And Their Use In Therapy App 20120283288 - Springer; Caroline ; et al.	2012-11-08
Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use App 20120238568 - Springer; Caroline Joy ; et al.	2012-09-20
Pyrido[2,3-b]pyrazin-8-substituted compounds and their use Grant 8,198,279 - Springer , et al. June 12, 2	2012-06-12
Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds Grant 7,951,819 - Niculescu-Duvaz , et al. May 31, 2	2011-05-31
Aryl-Quinolyl Compounds and Their Use App 20110053946 - Niculescu-Duvaz; Ion ; et al.	2011-03-03
Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use App 20100298320 - Springer; Caroline Joy ; et al.	2010-11-25
Imidazo[4, 5-b]pyridin-2-one And Oxazolo[4, 5-b]pyridin-2-one Compounds And Analogs Thereof As Cancer Therapeutic Compounds App 20090325945 - Niculescu-Duvaz; Dan ; et al.	2009-12-31
Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds Grant 7,625,922 - Niculescu-Duvaz , et al. December 1, 2	2009-12-01
Imidazo[4,5-B]Pyridin-2-One and Oxazolo[4,5-B]Pyridin-2-One Compounds and Analogs Thereof as Therapeutic Compounds App 20070287838 - Niculescu-Duvaz; Dan ; et al.	2007-12-13
Methods of chemical systhesis of phenolic nitrogen mustard prodrugs Grant 6,916,949 - Springer , et al. July 12, 2	2005-07-12
Methods of chemical systhesis of phenolic nitrogen mustard prodrugs App 20040087813 - Springer, Caroline Joy ; et al.	2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.